NCT01224834

Safety and Tolerability Study of Ragweed SLIT Tablets

Phase I Study to Investigate the Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy Tablets Given in Single Rising Doses and in Multi Dose Regimens to Subjects With an Allergy to Ragweed Pollen.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Stallergenes Greer · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the safety and tolerability of several doses of ragweed pollen allergen extract administered as sublingual tablets in subjects with allergic rhinitis to ragweed.

Conditions

• Rhinitis, Allergic, Seasonal
• Ragweed Pollen Allergy

Interventions

Type	Name	Description
DRUG	Sublingual tablet of ragweed pollen allergen extract	administered once a day over 10 days

Timeline

• Start date: 2009-01-01
• Primary completion: 2009-04-01
• Completion: 2009-10-01
• First posted: 2010-10-20
• Last updated: 2010-11-08

Locations

1 site across 1 country: Hungary